IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $599 | +75.7% | 15,242 | +8.6% | 0.08% | +145.2% |
Q1 2023 | $341 | -99.9% | 14,038 | -28.3% | 0.03% | -11.4% |
Q3 2022 | $351,000 | -46.5% | 19,585 | -71.3% | 0.04% | -52.7% |
Q2 2022 | $656,000 | +909.2% | 68,147 | +560.4% | 0.07% | +957.1% |
Q2 2021 | $65,000 | -46.3% | 10,319 | -41.2% | 0.01% | -65.0% |
Q4 2020 | $121,000 | – | 17,543 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |